Showing results (61-70 of 773) with videos related to
Sort By:
Pageof 78
Health Affairs (Project Hope)|October 11, 2012
The Food and Drug Administration has the legal basis to restrict promotion of flawed comparative effectiveness researchAaron S Kesselheim, Jerry AvornThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 5, 2009
Using patent data to assess the value of pharmaceutical innovationAaron S Kesselheim, Jerry AvornArchives of Internal Medicine|March 10, 2004
Which patients with knee problems are likely to benefit from nonarthroplasty surgery? Development of a clinical prediction ruleDaniel H Solomon, Jerry Avorn, Asra Warsi, et al.Arthritis Research & Therapy|March 18, 2006
The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28Masayo Sato, Sebastian Schneeweiss, Richard Scranton, et al.Journal of Hypertension|February 7, 2007
Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based studyBoris L G van Wijk, Jerry Avorn, Daniel H Solomon, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 25, 2007
Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician educationDaniel H Solomon, Jeffrey N Katz, Joel S Finkelstein, et al.Arthritis and Rheumatism|September 2, 2006
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritisSoko Setoguchi, Daniel H Solomon, Michael E Weinblatt, et al.International Quarterly of Community Health Education|September 2, 2009
High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in PennsylvaniaJennifer M Polinski, Suzanne M Cadarette, Marilyn Arnold, et al.Circulation. Cardiovascular Quality and Outcomes|October 25, 2012
Origins of medical innovation: the case of coronary artery stentsShuai Xu, Jerry Avorn, Aaron S KesselheimPageof 78